ITGAX and B-cell chronic lymphocytic leukemia: We found that while the CD11b blocking antibody had no significant effect on migration (Fig 4A), inhibiting CR4 with a CD11c specific antibody resulted in a significant decrease in the number of migrated CLL-B cells (Fig 4B).